Found 15591 matches for
Baricitinib – an anti-inflammatory treatment for rheumatoid arthritis– is being investigated in the RECOVERY trial, the world’s largest clinical trial of treatments for patients hospitalised with COVID-19, taking place in 177 hospital sites across the UK and with over 33,000 patients recruited so far. As an anti-inflammatory, baricitinib may block the signalling activity of cytokine molecules which contribute to the hyper-inflammatory state seen in severe COVID-19. It is thought that baricitinib may act also have some anti-viral activity. The other treatments currently being investigated in the RECOVERY trial are Regeneron’s antibody cocktail, Aspirin and Colchicine.
Brochure describing the Oxford Centre for Global Health Research. This file contains minor issues with images and reading order, and we apologies for this. An accessible version (without images) can be found at https://www.tropicalmedicine.ox.ac.uk/files/ocghr-files/building-a-global-health-community.pdf
Accessible version (no images and no issue with reading order) of the OCGHR Building a Global Health Community brochure
Brochure describing the various themes underlying research at OCGHR: Better data and evidence, Innovation and implementation, Sharing knowledge and strengthening capacity, Enhancing policy and practice, Strengthening healh and research systems
Sir David’s recollections of how MORU came about - this old PDF was checked and made more accessible, as much as we could. We apologise for the inconvenience
Slide of Rogier van Doorn presentation for TropMed webinar on AMR surveillance, October 2020
PDF slides of Paul Turner from our COMRU unit in Cambodia telling us about the pressing need for quality laboratory data in low and middle income countries, for better antimicrobial resistance surveillance. TropMed webinar on AMR surveillance, October 2020